Cite
HARVARD Citation
Kiyota, N. et al. (n.d.). 2864 Defining 131I-refractory differentiated thyroid cancer: efficacy and safety of lenvatinib by 131I-refractory criteria in the SELECT trial. European journal of cancer. pp. S578-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kiyota, N. et al. (n.d.). 2864 Defining 131I-refractory differentiated thyroid cancer: efficacy and safety of lenvatinib by 131I-refractory criteria in the SELECT trial. European journal of cancer. pp. S578-. [Online].